Core Laboratories NV (CLB)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 520,526 | 517,009 | 504,808 | 498,822 |
| Receivables | US$ in thousands | 127,355 | 132,375 | 130,731 | 129,535 |
| Receivables turnover | 4.09 | 3.91 | 3.86 | 3.85 |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $520,526K ÷ $127,355K
= 4.09
The receivables turnover ratio for Core Laboratories NV has exhibited a gradual increase over the year. Starting at 3.85 in March 2024, the ratio improved to 3.86 in June 2024, further increased to 3.91 by September 2024, and finally reached 4.09 by December 2024. This trend indicates that the company is collecting its accounts receivable more efficiently, converting outstanding receivables into cash at a faster pace. A higher receivables turnover ratio typically signifies a more effective credit and collection process, which is a positive indicator of the company's liquidity and financial health.
Peer comparison
Dec 31, 2024